Enews from the Alzheimer's Association

Having trouble viewing this message? You may view it as a web page. You may also view e-news archives.
To prevent mailbox filters from deleting your Alzheimer's Association email communications, please add alzheimers_enews@alz.org to your address book.
January 11, 2023
24/7 Helpline: 800.272.3900
Alzheimer’s Association welcomes FDA approval of lecanemab
The Alzheimer’s Association enthusiastically welcomes the U.S. Food and Drug Administration’s (FDA) action to grant the accelerated approval of lecanemab (Leqembi™) for the treatment of patients in the mild cognitive impairment (MCI) or mild dementia stage of Alzheimer’s disease and with confirmation of beta-amyloid. The Association also renews the urgent call for the Centers for Medicare & Medicaid Services to cover FDA-approved Alzheimer’s treatments.

Click here to read more
Traumatic brain injury may increase risk of cognitive decline
Whether it's due to slipping on an icy sidewalk, a sports-related collision or even a mishap on the playground, bumps to the head are common. In the latest issue of ALZ magazine, experts discuss the relationship between the severity of traumatic brain injury and an increased risk of cognitive decline.
Click here to read more
Help fight Alzheimer's
Your Local Community
Alzheimer's affects people living with the disease in different ways
Alzheimer's typically progresses slowly in three general stages: mild (early stage), moderate (middle stage) and severe (late stage). Each person living with Alzheimer's will experience symptoms and progress through the stages of the disease in different ways.
Click here to read more
Create a free, customized action plan with Alzheimer's Navigator.
More Resources: 
Behaviors  | 
My Preferences:
To stop receiving our weekly e-newsletter, simply unsubscribe.
Was this e-newsletter forwarded to you? Subscribe to get it weekly.
The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support.

Alzheimer's Association Home Office 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601
© 2023 Alzheimer's Association. All rights reserved. www.alz.org | 800.272.3900.